This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
SANDOZ LOSARTAN HCT
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of SANDOZ LOSARTAN HCT in Canada?
Yes. SANDOZ LOSARTAN HCT 12.5MG 100MG has an active shortage reported to Health Canada (last updated September 8, 2026).
Why is SANDOZ LOSARTAN HCT not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will SANDOZ LOSARTAN HCT be available again?
The estimated resolution date (September 11, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02362449
Strength
12.5MG 100MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Tier
Unrated
Last Updated
2026-07-07
Reason for Shortage
Demand increase for the drug.
Past Reports for This Drug
SANDOZ LOSARTAN HCT has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759